{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:21:07Z","timestamp":1789827667717,"version":"4.0.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Colorectal adenomas have the potential of malignant transformation if left untreated. Multiple randomized controlled trials have been performed to evaluate the efficacy of aspirin in preventing colorectal adenoma recurrence in a population with a history of colorectal adenoma but not colorectal cancer, however, the relationship between aspirin dose and colorectal adenoma recurrence remains unclear. We conducted pairwise meta-analysis, meta-regression, trial sequential analysis, and network meta-analysis of all eligible studies. The ROB 2.0 tool was used to assess the risk of bias in the studies. The confidence in network meta-analysis (CINeMA) approach was used to evaluate the confidence of the network meta-analysis results. The network meta-analysis included eight RCTs (nine reports), comprising four on aspirin (low or high dose) alone and four on aspirin combined with another medication, all compared with placebo. In the network meta-analysis, low-dose aspirin (LDA &lt;300 mg per day) was more effective than high-dose aspirin (HDA \u2265300 mg per day) and placebo, with risk ratios of 0.76 (95% CI: 0.58 to 0.99) and 0.7 (95% CI: 0.54 to 0.91), respectively. LDA was the optimal treatment relative to HDA and placebo (P-score = 0.99). In the trial sequential analysis, LDA was only more effective than placebo when the number of included participants exceeded the optimal information size; this was not the case for HDA. LDA has statistically significant efficacy for colorectal adenoma prevention, but compared with HDA, its efficacy remains uncertain. Further trials are therefore required.<\/jats:p>","DOI":"10.1371\/journal.pone.0279784","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:25:18Z","timestamp":1710422718000},"page":"e0279784","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Oral aspirin for preventing colorectal adenoma recurrence: A systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1371","volume":"19","author":[{"given":"Khanh Dinh","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-No","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1595-6553","authenticated-orcid":true,"given":"Chiehfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"issue":"4","key":"pone.0279784.ref001","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/gut.2003.026112","article-title":"Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese","volume":"53","author":"Y. Yamaji","year":"2004","journal-title":"Gut"},{"key":"pone.0279784.ref002","unstructured":"M. Meseeha and M. Attia, \"Colon Polyps,\" in StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC., 2022."},{"issue":"1","key":"pone.0279784.ref003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010130","article-title":"Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements","volume":"22","author":"A. Malki","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"pone.0279784.ref004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","article-title":"Estimates of the cancer incidence and mortality in Europe in 2006","volume":"18","author":"J. Ferlay","year":"2007","journal-title":"Ann Oncol"},{"issue":"6","key":"pone.0279784.ref005","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/cncr.2820360944","article-title":"The evolution of cancer of the colon and rectum","volume":"36","author":"T. Muto","year":"1975","journal-title":"Cancer"},{"issue":"12","key":"pone.0279784.ref006","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/sj.bjc.6601007","article-title":"A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy","volume":"88","author":"C. D. Chen","year":"2003","journal-title":"British journal of cancer"},{"issue":"1\u20132","key":"pone.0279784.ref007","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3959(03)00003-4","article-title":"Memories of colonoscopy: a randomized trial","volume":"104","author":"D. A. Redelmeier","year":"2003","journal-title":"Pain"},{"key":"pone.0279784.ref008","first-page":"2017","article-title":"Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas","volume":"1","author":"Y. Yao","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"pone.0279784.ref009","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1093\/jn\/136.7.1896","article-title":"High Dry Bean Intake and Reduced Risk of Advanced Colorectal Adenoma Recurrence among Participants in the Polyp Prevention Trial","volume":"136","author":"E. Lanza","year":"2006","journal-title":"The Journal of Nutrition"},{"issue":"1","key":"pone.0279784.ref010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1186\/s12885-017-3757-8","article-title":"Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials","volume":"17","author":"S. K. Veettil","year":"2017","journal-title":"BMC Cancer"},{"key":"pone.0279784.ref011","unstructured":"F. Macrae, Chetcuti, A, Julie Clarke, Emery, J, Professor Mark Jenkins PhD BSc, Trevor Lockett, McNeil, J, Prof Allan Spigelman, Dr Aung Ko Win, A\/Prof Robyn Woods, Young, G, \"[Pachter],[NP]\", Professor John Zalcberg MB BS, PhD, FRACP, FRACMA FAICD, Cancer Council Australia Colorectal Cancer Guidelines Working Party. \"Clinical question:Aspirin for prevention of colorectal cancer. In: Clinical practice guidelines for the prevention, early detection and management of colorectal cancer.\" [Version URL: https:\/\/wiki.cancer.org.au\/australiawiki\/index.php?oldid=196954, cited 2023 Apr 15]. https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Colorectal_cancer (accessed."},{"issue":"11","key":"pone.0279784.ref012","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"B. Hutton","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0279784.ref013","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5195\/jmla.2021.1260","article-title":"EndNote 20 desktop version","volume":"109","author":"T. Gotschall","year":"2021","journal-title":"J Med Libr Assoc"},{"key":"pone.0279784.ref014","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"J. A. C. Sterne","year":"2019","journal-title":"Bmj"},{"key":"pone.0279784.ref015","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","author":"L. A. McGuinness","year":"2020","journal-title":"Research Synthesis Methods"},{"key":"pone.0279784.ref016","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"J. A. Sterne","year":"2011","journal-title":"Bmj"},{"key":"pone.0279784.ref017","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"J. P. Higgins","year":"2019"},{"key":"pone.0279784.ref018","doi-asserted-by":"crossref","first-page":"f7450","DOI":"10.1136\/bmj.f7450","article-title":"Converting an odds ratio to a range of plausible relative risks for better communication of research findings","volume":"348","author":"R. L. Grant","year":"2014","journal-title":"Bmj"},{"issue":"4","key":"pone.0279784.ref019","doi-asserted-by":"crossref","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"A. Nikolakopoulou","year":"2020","journal-title":"PLoS Med."},{"issue":"1","key":"pone.0279784.ref020","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"T. Papakonstantinou","year":"2020","journal-title":"Campbell Systematic Reviews"},{"key":"pone.0279784.ref021","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"M. A. Puhan","year":"2014","journal-title":"Bmj"},{"issue":"12","key":"pone.0279784.ref022","first-page":"Cd011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"12","author":"E. Sbidian","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"pone.0279784.ref023","doi-asserted-by":"crossref","first-page":"138","DOI":"10.17085\/apm.21038","article-title":"Trial sequential analysis: novel approach for meta-analysis","volume":"16","author":"H. Kang","year":"2021","journal-title":"Anesth Pain Med (Seoul)"},{"issue":"10","key":"pone.0279784.ref024","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"R. S. Sandler","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0279784.ref025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.gastro.2007.10.014","article-title":"Aspirin and folic acid for the prevention of recurrent colorectal adenomas","volume":"134","author":"R. F. Logan","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0279784.ref026","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cam4.46","article-title":"Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial","volume":"2","author":"H. Ishikawa","year":"2013","journal-title":"Cancer Med"},{"issue":"6","key":"pone.0279784.ref027","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2468-1253(21)00018-2","article-title":"Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial","volume":"6","author":"H. Ishikawa","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10164","key":"pone.0279784.ref028","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/S0140-6736(18)31775-6","article-title":"Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2\u2008\u00d7\u20082 factorial trial","volume":"392","author":"M. A. Hull","year":"2018","journal-title":"Lancet"},{"issue":"24","key":"pone.0279784.ref029","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","article-title":"Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome","volume":"359","author":"J. Burn","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0279784.ref030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2011-300113","article-title":"Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial","volume":"61","author":"R. Benamouzig","year":"2012","journal-title":"Gut"},{"issue":"2","key":"pone.0279784.ref031","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","article-title":"Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial","volume":"125","author":"R. Benamouzig","year":"2003","journal-title":"Gastroenterology"},{"issue":"10","key":"pone.0279784.ref032","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"J. A. Baron","year":"2003","journal-title":"N Engl J Med"},{"issue":"15","key":"pone.0279784.ref033","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jnci\/85.15.1220","article-title":"Low-dose aspirin and incidence of colorectal tumors in a randomized trial","volume":"85","author":"P. H. Gann","year":"1993","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"pone.0279784.ref034","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12876-021-01715-7","article-title":"Very-low-dose aspirin and surveillance colonoscopy is cost-effective in secondary prevention of colorectal cancer in individuals with advanced adenomas: network meta-analysis and cost-effectiveness analysis","volume":"21","author":"S. K. Veettil","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"pone.0279784.ref035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.scitotenv.2012.10.092","article-title":"Lower-dose prescribing: minimizing \"side effects\" of pharmaceuticals on society and the environment","volume":"443","author":"C. G. Daughton","year":"2013","journal-title":"Sci Total Environ"},{"issue":"3\u20134","key":"pone.0279784.ref036","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3121\/cmr.2013.1197","article-title":"The role of aspirin in the prevention of cardiovascular disease","volume":"12","author":"S. V. Ittaman","year":"2014","journal-title":"Clin Med Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0279784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:25:55Z","timestamp":1710422755000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0279784"}},"subtitle":[],"editor":[{"given":"Rodney John","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0279784","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.12.15.22283547","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}